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ABSTRACT
Mof4 family associated protein 1 (MRFAP1) is a 14 kDa nuclear protein, which
involves in maintaining normal histone modification levels by negatively regulating
recruitment of the NuA4 (nucleosome acetyltransferase of H4) histone acetyltransferase
complex to chromatin. MRFAP1 has been identified as one of the most up-regulated
proteins after NEDD8 (neural precursor cell expressed developmentally downregulated 8) inhibition in multiple human cell lines. However, the biological function of
MRFAP1 and the E3 ligase that targets MRFAP1 for destruction remain mysterious. Here
we show, by using an immunoprecipitation-based proteomics screen, that MRFAP1 is an
interactor of the F-box protein FBXW8. MRFAP1 is degraded by means of the ubiquitin
ligase Cul7/FBXW8 during mitotic anaphase-telophase transition and accumulated in
mitotic metaphase. Overexpression of FBXW8 increased the polyubiquitination and
decreased the stability of MRFAP1, whereas knockdown of FBXW8 prolonged the halflife of MRFAP1. Moreover, forced expression of MRFAP1 in HeLa cells caused growth
retardation and genomic instability, leading to severe mitotic cell death. Thus, Cul7/
FBXW8-mediated destruction of MRFAP1 is a regulatory component monitoring the
anaphase-telophase transition and preventing genomic instability.

INTRODUCTION

system is mainly determined by E3 ubiquitin ligases [2].
The Cullin-Ring Ligases (CRL) are the well-studied RING
E3 ubiquitin ligases, among which the Skp1-Cullin1-Fbox
(SCF) complex has been extensively characterized. To date,
the Cullin family contains eight mammalian proteins, Cul1,
Cul2, Cul3, Cul4A, Cul4B, Cul5, Cul7 and Cul9 [3].

The specific, rapid, and temporally controlled
proteolysis of cellular regulators by the ubiquitinproteasome system (UPS) determined the unidirectional
progression through the cell cycle [1]. The specificity of this
www.impactjournals.com/oncotarget
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The SCF complexes compose of the scaffold
protein Cul1, the RING finger protein Rbx1 and the
adaptor protein Skp1 to bridge variable F-box proteins
that determine substrate recognition and recruitment
to the SCF complexes [4]. The human genome encodes
more than 70 F-box proteins that contain a homologous
40-amino-acid F-box domain which can be further divided
into three major classes: the FBXW family, the FBXL
family, and the FBXO family [5]. Among these F-box
proteins, FBXW8 is not only the receptor component of an
SCF complex, but also the unique F-box protein known to
interact with Cul7 [6]. Cul7 interacts directly with FBXW8
and indirectly with Skp1 in an FBXW8-dependent manner
[6]. Interestingly, Cul7 has higher affinity with FBXW8
than Cul1, and the placental phenotypes of FBXW8-/and Cul7-/- mice are similar, indicating that Cul7 forms
a ubiquitin E3 ligase complex with FBXW8 to target
substrates for destruction [7]. In agreement with that, Cul7/
FBXW8 ubiquitin ligase-mediated HPK1 (hematopoietic
progenitor kinase-1) degradation played a critical role in
cell proliferation and differentiation [8].
Mof4 family associated protein 1 (MRFAP1) is
highly conserved and only presents in mammals, which
is consistent with its specific role in the regulation of
mortality factor 4 like 1 (MORF4L1) protein complexes.
MRFAP1 maintains the normal histone modification
levels by negatively regulating recruitment of the NuA4
histone acetyltransferase complex to chromatin [9]. It
also regulates the transcription factors activities of the
MRG family (Mas-related genes) via competing with
MRGBP for binding to MORF4L1, and plays a role
in spermatogenesis, possibly by regulating the hyperacetylation of chromatin on histone H4 [10]. Recently, by
quantitative proteomic analysis, MRFAP1 has been shown
to be degraded by CRL via the ubiquitin-proteasome
system [10, 11]. However, which CRL family member
involved in this process remains unknown.
In this study, by using an immunoprecipitationbased proteomics screen, we identified that MRFAP1 was
an interactor of FBXW8. MRFAP1 was a novel cell cycleregulated protein degraded by Cul7/FBXW8 ubiquitin
ligase during mitotic anaphase-telophase transition and
accumulated in mitotic metaphase. Failure to degrade
MRFAP1 in HeLa cells caused growth retardation and
genomic instability, leading to severe mitotic cell death.

of NEDD8-activating enzyme, which specifically disrupts
CRLs-mediated protein turnover, was used to prevent the
degradation of potential FBXW8 substrates and might
enhance the protein-protein interactions with FBXW8.
The cell lysate from Flag-control or Flag-FBXW8 293T
cells with 4 hours MLN4924 treatment were subjected to
immunoprecipitation with anti-Flag M2 resin to purify
SCF-FBXW8 complexes. The whole IP procedure was
monitored by running all separated cell lysate components
on SDS-PAGE, followed by Coomassie Brilliant Blue
staining (Figure 1A). The gel was continuously cut and
subjected to LC−MS/MS analysis. The results indicate that
Cul7 but not Cul1 was the highest score interacting protein
of FBXW8 group (data not shown) as expected. Among
a number of peptides from putative novel substrates,
we recovered two unique peptides from MRFAP1
(EDIASLTR and TQVEASEESALNHLQNPGDAAEGR)
(Figure 1B). The affinity efficiency for Flag-FBXW8 was
very high, as almost all exogenously expressed FBXW8
was accumulated in the elution group (Figure 1A).
Moreover, MRFAP1 was detected in the final elution of
Flag-FBXW8 group and flow through of both groups
(Figure 1A), suggesting that at least one part of endogenous
MRFAP1 was specifically associated with FBXW8.

MRFAP1 is co-localized and associated with
FBXW8
To determine the subcellular distribution of FBXW8,
and further verify the spatio-temporal possibility that
FBXW8 and MRFAP1 might interact with each other in
mammalian cells in vivo, we utilized immunofluorescence
microscopy on HeLa cells co-expression of Flag-FBXW8
and GFP-MRFAP1. As shown in Figure 2A, FBXW8 was
distributed throughout the cytoplasm and less expressed
in the nucleus of interphase cells. However, most
MRFAP1 was distributed in the nucleus. Nevertheless,
in agreement with our biochemistry data, the overlapping
between FBXW8 and MRFAP1 in the nucleus was clearly
observed (Figure 2A). Moreover, the interaction between
exogenous FBXW8 and MRFAP1 was also confirmed by
immunoprecipitation with either GFP or Flag antibodies
(Figure 2B). Taken together, these data suggested that
MRFAP1 was associated with FBXW8.

FBXW8 regulates MRFAP1 ubiquitination and
degradation

RESULTS
Proteomics screen identified MRFAP1 as a
potential binding partner of Cul7/FBXW8 E3
ligase complex

Given the specific interaction between FBXW8 and
MRFAP1, we then asked whether FBXW8 regulates the
stability of MRFAP1. We found that depletion of FBXW8
by siRNAs consistently increased the basal expression
level of endogenous MRFAP1 (Figure 3A). Furthermore,
overexpression of FBXW8 caused the decrease of endogenous
MRFAP1 in a dose-dependent manner, which was rescued
by proteasome inhibitor MG132 (Figure 3B), indicating

To systematically identify the candidate substrates
of Cul7/FBXW8, we performed an immunoprecipitationbased proteomics screen in 293T cell stably expressing
Flag-FBXW8. MLN4924, a potent and selective inhibitor
www.impactjournals.com/oncotarget
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that FBXW8 regulated the expression of MRFAP1 at
posttranscriptional level. Indeed, overexpression of FBXW8
significantly promotes the ubiquitination of MRFAP1,
suggesting FBXW8 targets MRFAP1 for proteasomemediated degradation (Figure 3C). Moreover, 293T cells were
treated with cycloheximide (CHX) to block protein synthesis.
We found that overexpression of FBXW8 decreased the halflife of MRFAP1 (Figure 4A–4B), whereas knockdown of
FBXW8 prolonged it (Figure 4C–4D). In summary, these data
demonstrate that FBXW8 regulates MRFAP1 ubiquitination
and degradation.

the culture after the release from double thymidine arrest
to activate the spindle checkpoint and prevent exit from
mitosis. DNA contents of those cells were monitored by
flow cytometry analysis (FACS), and lysates of these cells
were tested by immunoblotting. As shown in Figure 5A,
the protein level of MRFAP1 significantly increased after
cells entering into mitosis. However, the protein level of
FBXW8 remained unaltered. Interestingly, the increase
of MRFAP1 protein level was even early than CyclinB1,
which is known to be accumulated in early mitosis. In
order to check how MRFAP1 was regulated when cells
released from M phase, HeLa cells stably expressing
Flag-MRFAP1, which were synchronized by nocodazole
block-and-release, were analyzed by FACS and lysates of
these cells were tested by immunoblotting (Figure 5B).
As expected, MRFAP1 was highly accumulated in
mitosis. However, as cells exited from M phase, MRFAP1
decreased gradually (Figure 5B). In line with these
observations, by using immunofluorescence, we found that
MRFAP1 was accumulated in metaphase, but completely
disappeared in anaphase and reappeared in telophase

Cell cycle-dependent degradation of MRFAP1
Because SCF E3 ligase mediates the ubiquitination
of several proteins in specific phases of the cell cycle, we
also analyzed the expression of MRFAP1 during the cell
cycle. Firstly, we created a HeLa cell line stably expressing
Flag-MRFAP1. These cells were synchronized by double
thymidine arrest, released, and collected at various time
points after release. In addition, nocodazole was added to

Figure 1: Proteomics screen identified MRFAP1 as a potential binding partner of Cul7/FBXW8 E3 ligase complex.

(A) After 4 hours 1 µM MLN4924 treatment, lysates from 293T cells stably expressing either Flag or Flag-FBXW8 were immunoprecipitated
with anti-FLAG M2 resin. Bound proteins were eluted with FLAG peptide, and all separated cell lysate components were resolved on 10%
SDS-PAGE gel, stained by Coomassie Brilliant or subjected to immunoblotting with the indicated antibodies. The gel was continuously cut
and subjected to LC−MS/MS analysis. (B) MRFAP1 was identified as a potential binding partner of FBXW8. Two unique peptides were
assigned to MRFAP1 from MLN4924 treated Flag-FBXW8 but not FLAG-control 293T cell line.
www.impactjournals.com/oncotarget
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Overexpression of MRFAP1 causes mitotic
aberrations and cell death

(Figure 5C, top panel). However, silencing the expression
of FBXW8 prevented the disappearance of MRFAP1
in anaphase (Figure 5C, bottom panel). Taken together,
the data validate that MRFAP1 is a novel cell cycleregulated protein and cell cycle-dependent degradation of
MRFAP1was mediated by FBXW8.

Cell cycle is a precisely regulated process and cell
cycle regulated-proteins usually play crucial roles in
the regulation processes. Thus, the cell cycle-dependent

Figure 2: MRFAP1 is associated with FBXW8. (A) HeLa cells were co-transfected with GFP-MRFAP1 (green) and Flag-

FBXW8 (red) vectors for 36 hours, cells were then fixed and stained with anti-Flag antibody. Cell nuclei were stained with DAPI.
Immunofluorescence was performed with anti-flag antibody followed by Alexa Fluor 594-conjugated anti-mouse IgG antibody (red). Bar
indicated 20 μm. (B) 293T cells were co-transfected with GFP-MRFAP1 and Flag-FBXW8 vectors for 36 hours, the cell lysates were
subjected to immunoprecipitation with either GFP or Flag antibodies. Western blot was used to detect the interactions between FBXW8
and MRFAP1.

Figure 3: FBXW8 regulates MRFAP1 ubiquitination and degradation. (A) 293T cells were transfected with negative control

or three siRNAs against FBXW8 for 36 hours. The whole cell lysate was subjected to Western blot by the indicated antibodies. (B) 293T
cells were transfected with increase dose of Flag-FBXW8 plasmids for 36 hours. 10 μM MG132 was added for 6 hours as indicated, and
the whole cell lysate was subjected to Western blot by the indicated antibodies. (C) 293T cells were transfected with Flag-MRFAP1,
GFP-FBXW8 or HA-Ubiquitin for 30 hours. After 6 hours MG132 treatment, samples were immunoprecipitated with anti-flag resin, and
analyzed by immunoblotting with the indicated antibodies.
www.impactjournals.com/oncotarget
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degradation of MRFAP1 by FBXW8 during mitosis
intrigues us to further investigate its biological function
in cell cycle control. Aberrant expression of cell cycle
regulated-proteins could lead to genome instability, we
therefore tested whether MRFAP1 was involved in the
regulation of genome stability. As depicted in Figure 6A,
overexpression of MRFAP1 in HeLa cells induced mitotic
aberrations including binuclear cells, multi-lobed nuclei
cells and cell death. In contrast, all these defects were hardly
observed in GFP overexpressed HeLa cells. In agreement,
HeLa cells with MRFAP1 overexpression exhibited a
growth retardant phenotype (Figure 6B). Indeed, HeLa
cells with prolonged MRFAP1 expression showed severe
cell death by the morphological confirmation, FACS assay
determination as well as the activation and cleavage of
caspase-3 (Figure 6C–6F), indicating that failure to degrade
MRFAP1 in cells produced chromosome instability and
eventually lead to cell death.

most substrates are rapidly ubiquitylated and degraded
as a result of their association with E3 ligase. The
administration of proteasome inhibitors such as MG132
prevented the degradation of substrates might help to
improve the identification of substrates of E3 ligases,
but without sufficient specificity. MLN4924, a potent
and selective inhibitor of NEDD8-activating enzyme,
specifically disrupts CRLs-mediated protein turnover
[12]. Previous studies showed that substrates of CRLs
were highly accumulated upon MLN4924 administration,
giving the possibility to identify the substrates of CRLs by
Mass Spectrum (MS) [13–15]. In this study, we performed
an immunoprecipitation-based proteomics screen with
MLN4924 treatment to identify the candidate substrates
of Cul7/FBXW8 and demonstrated MRFAP1 as a bona
fide substrate of FBXW8.
After MRFAP1 has been shown to be one of the
most up-regulated proteins after NEDD8 inhibition
in multiple human cell lines [10], we tested whether
MRFAP1 was regulated by FBXW8. The association
between MRFAP1 and FBXW8 was confirmed by
means of immunoprecipitation-Western blot as well as
exogenous indirect immunostaining. Overexpression of

DISCUSSION
The identification of substrates for ubiquitin E3
ligases by proteomic assay is extremely difficult, as

Figure 4: FBXW8 regulates the stability of MRFAP1. (A) 293T cells were transfected with empty vector or FBXW8 plasmids for 36

hours, 10 μM CHX was added for the indicated time. The whole cell lysate were detected by Western blot (A) using the indicated antibodies.
(B) The intensity of the bands from the experiment shown on A was measured, and the ratio between the relative levels of MRFAP1 and
β-actin in 0 hour was set as 1.0. (C) 293T cells were transfected with siRNAs targeting FBXW8 or negative control for 36 hours, 10 μM CHX
was added for the indicated time. The whole cell lysate were detected by Western blot using the indicated antibodies. (n = 3 for each group).
(D) The intensity of the bands from the experiment shown on C was measured, and the ratio between the relative levels of MRFAP1 and
β-actin in 0 hour was set as 1.0.
www.impactjournals.com/oncotarget
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FBXW8 increased the polyubiquitination and decreased
the stability of MRFAP1, whereas knockdown of FBXW8
prolonged the half-life of MRFAP1, demonstrating that
MRFAP1 is the bone fide substrate of Cul7/FBXW8.
Substrates of F-box proteins usually involved in cell cycle
control and FBXW8 also played a role in cell proliferation,
we then examined the expression level of MRFAP1 in cell

cycle progress. Interestingly, we found MRFAP1 was a
novel cell cycle-regulated protein that accumulated in
metaphase, but disappeared thoroughly in anaphase and
reappeared in telophase. Importantly, this disappearance
could be abolished by FBXW8-depletion, suggesting that
FBXW8-mediated MRFAP1 degradation might play a role
in the progression of normal cell cycle. Indeed, forced

Figure 5: Cell cycle-dependent degradation of MRFAP1. (A) HeLa cells stably expressing Flag-MRFAP1 was synchronized by

thymidine for 24 hours. Nocodazole was added to the culture after the release from thymidine arrest. The cells were collected at the indicated
time and analyzed by FACS. Lysates of these cells were tested by Western blot with the indicated antibodies. (B) HeLa cells stably expressing
Flag-MRFAP1 was synchronized by thymidine for 12 hours, release for 3 hours, and then blocked by nocodazole for 12 hours. After release
from the nocodazole block, the cells were collected at the indicated time and analyzed by FACS. Lysates of these cells were tested by
immunoblotting with the indicated antibodies. (C) HeLa cells stably expressing Flag-MRFAP1 were transfected with siRNAs targeting
FBXW8 or negative control for 36 hours, fixed with PFA and stained with anti-Flag antibody. Various stage of mitosis cells were shown Int
(interphase), Pro (prophase), Mid (metaphase), Ana (anaphase), Tel (telophase). Nucleus was stained with DAPI. Bar indicated 10 μm.

Figure 6: Overexpression of MRFAP1 causes mitotic aberrations and cell death. (A) HeLa cells were transfected with

pEGFP-N1-MRFAP1 plasmid for 24 hours and fixed with PFA. Nucleus was stained with DAPI. Arrows indicated the binuclear cells
or multi-lobed nuclei cells. Bar indicated 10 μm. The percentage of the abnormal mitotic cells was calculated. (n = 3 for each group).
(B) HeLa cells were transfected with empty vector or pEGFP-N1-MRFAP1 plasmids for 24 hours, cell proliferation were tested by CCK8
assay. (n = 5 for each group). (C) HeLa cells were transfected with empty vector or pEGFP-N1-MRFAP1 plasmids for 24 hours, subG1
ratio was analyzed by FACS. (D) HeLa cells were transfected with empty vector or pEGFP-N1-MRFAP1 plasmids for 24 hours, and
Annexin V positive cells was determined on flow cytometry. (E) HeLa cells were transfected with empty vector or pEGFP-N1-MRFAP1
plasmids for 24 hours and fixed with PFA. Nucleus was stained with DAPI Arrows indicated the apoptosis cells. Bar indicated 50μm. The
percentage of the apoptosis cells was calculated. (n = 3 for each group). (F) HeLa cells were transfected with empty vector or pEGFP-N1MRFAP1 plasmids for 24 hours, cells were then lysed and subjected to western blot with cleaved caspase-3 antibody.
www.impactjournals.com/oncotarget
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expression of MRFAP1 in HeLa cells caused growth
retardation and genomic instability, and eventually leading
to severe mitotic cell death.
Although F-box proteins tend to recognize specific
degron sequences within target substrates, prior modifications
of these degrons are usually required to trigger the interaction
between F-box proteins and their substrate proteins, such
as phosphorylation, glycosylation and acetylation [4, 16].
To this end, we have also purified MRFAP1 protein and
determined the potential phosphorylation sites of it by MS.
However, we could not identify any phosphorylation sites
(data not shown) and MRFAP1 itself has not been reported to
be phosphorylated even in public phosphorylation database,
suggesting phosphorylation might not be required for the
interaction between MRFAP1 and FBXW8. Nevertheless,
further studies are required to clarify the interacting details
between MRFAP1 and FBXW8.
Although we have confirmed that MRFAP1
overexpression resulted in decreased cell growth and increased
mitotic apoptosis, whether MRFAP1 contributes to DNA rereplication, DNA damage signaling, senescence or autophagy
(a phenomena could be observed after MLN4924 treatment)
remained completely unknown [17]. Thus, our data has set
up the stage for the MRFAP1 function, physiological and
pathophysiological significances related researches.
In summary, in this manuscript, by using an
immunoprecipitation-based proteomics screen, we
identified MRFAP1 was a novel cell cycle-regulated protein
and Cul7/FBXW8-mediated destruction of MRFAP1 could
be a regulatory component monitoring the anaphasetelophase transition and preventing genomic instability.

constructs were generated by gene synthesis and cloned into
the pEGFP-N1, pCDNA3.1(-), and pBABE-3XFlag vector.
The construction of retrovirus based stable expression cell
lines has been described previously [18].

CCK8 assay
HeLa cells were inoculated in a 96-well plate 24 hours
before transfection. CCK8 (cell counting kit C0038,
Beyotime Biotechnology, China) solution was added to each
well of the plate 24 hours after transfection. The plate was
then incubated for 4 hours in an incubator. The absorbance
at 450 nm was measured by using a microplate reader
(SpectraMax Paradigm, Molecular Devices, USA).

siRNAs
FBXW8-specific siRNAs were purchased from
RiboBio (Guangzhou, China). The siRNA sequences
for human FBXW8 were: No1 5′ GGAGCAUGUUC
CUGACACA 3′, No2 5′ GAAGCAAGAUCCUGGUGUA 3′,
No3 5′ CAGGAAAGAACUAGGAAGA 3′. 293T-MRFAP1
cell line was plated in a 24-well tissue culture plate for
20 to 24 hours before transfection. For transfection of
siRNAs, cells were transfected with 100 nM of siRNA
using 1 μL Lipofectamine® 2000 for each well. Cells were
then harvested 48 hours after transfection.

Protein purification, in-gel digestion and
Nano-LC−ESI−MS/MS analysis
The whole IP/MS analysis procedure has been
described previously [19].

MATERIALS AND METHODS

Immunofluorescence microscopy

Cell culture and treatments

Cells were cultured on glass coverslips as described
above and then fixed with 4% paraformaldehyde in
PBS. Fixed cells were washed with PBS and then
permeabilized using 1 % Triton X-100 for 10 min
followed by washing with PBS. Coverslips were
processed for immunolabeling by blocking with 5%
BSA in TBST. Cells were incubated with primary
antibodies in 5% BSA in TBST on coverslips for 1 hour.
The coverslips were washed with PBS for three times.
Primary antibodies were detected with Alexa Fluor 488
or Alexa Fluor 594-conjugated secondary antibodies
by incubating on coverslips for 30 min in 5% BSA in
TBST. Paraformaldehyde, Triton X-100, and BSA were
obtained from sinopharm chemical reagent co.,Ltd
(China). Alexa Fluor 488 or Alexa Fluor 594-conjugated
secondary antibodies were obtained from Invitrogen
(U.S.A). Anti-FLAG antibody (1:1000 dilution, F1804)
was purchased from Sigma, U.S.A, Polyclonal antiMRFAP1 (1:500 dilution, 11639-1-AP) was purchased
from Ptglab, Wuhan, Hubei, China, Polyclonal antiFBXW8 (1:500 dilution, sc-167864) was obtained from

293T and HeLa cells were purchased from the
American Type Culture Collection (ATCC). All cells
were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum in a 5%
CO2/95% air at 37°C under saturated humidity. Dulbecco’s
modified Eagle’s medium, fetal bovine serum and trypsin
were obtained from Invitrogen (U.S.A). MLN4924 (HY10484, NEDD8-Cullin E3 ligase pathway inhibitor) was
purchased from Med Chem Express (U.S.A). Puromycin
(P9620, selective agent in eukaryotic cell culture systems),
Thymidine (T1895, DNA synthesis inhibitor), MG132
(M8699, proteasome inhibitor), nocodazole (M1404, mitotic
spindle inhibitor), cycloheximide (C1988, eukaryote protein
synthesis inhibitor) and FLAG M2 Affinity Gel (A2220)
were obtained from Sigma (U.S.A).

Constructs and vectors
MRFAP1 (gene accession number: NM_001272053.1)
and FBXW8 (gene accession number: NM_012174.1)
www.impactjournals.com/oncotarget
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Santa cruz, U.S.A. Images were captured by fluorescence
microscopy (Bx53, Olympus, Japan).
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Western blot
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Cells were harvested and lysed with ice-cold
lysis buffer (62.5 mM Tris-HCl, pH 6.8, 100 mM
DTT, 2% SDS, 10 % glycerol). After centrifugation at
12,000 g for 10 min at 4°C, proteins in the supernatants
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